Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database

Hepatology

Volumn 48, Issue 3, 2008, Pages 878-888

  Balan, Vijayan ^a   Ruppert, Kris ^b   Demetris, A Jake ^b   Ledneva, Tatiana ^b   Duquesnoy, Rene J ^c   Detre, Katherine M ^b   Wei, Yuling L ^b   Rakela, Jorge ^a   Schafer, Daniel F ^d   Roberts, John P ^e   Everhart, James E ^f   Wiesner, Russell H ^g  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL DISEASE; GENE LOCUS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEX RATIO; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DATABASES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (U.S.); TACROLIMUS; TREATMENT OUTCOME; UNITED STATES;

EID: 51349144887     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22435     Document Type: Article

References (42)

1. Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, et al. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 2003;75:132-137.
2. Moore SB. Is HLA matching beneficial in liver transplantation? [comment]. Liver Transpl 2001;7:774-776.
3. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 2004;77:226-231.
4. Neumann UP, Langrehr JM, Naumann U, Lang M, Rayes N, Steinmuller T, et al. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis. Clin Transplant 2002; 16:122-129.
5. Poli F, Frison S, Cardillo M, Scalamogna M, Longhi E, Crespiatico L, et al. A retrospective analysis of HLA matching and other factors on liver graft outcome. Transplant Proc 2001;33:1368-1369.
6. Sugawara Y, Mizuta K, Kawarasaki H, Takayama T, Imamura H, Makuuchi M. Risk factors for acute rejection in pediatric living related liver transplantation: The impact of HLA matching [see comment]. Liver Transpl 2001;7:769-773.
7. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation [see comment]. Liver Transpl Surg 1998;4:22-27.
8. Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli-Vergani G, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998;66:53-58.
9. Dawson S III, Imagawa DK, Cecka JM, Gjertson DW, Shackleton CM, Shaked A, et al. UCLA liver transplantation: Analysis of the first 1,000 patients. Clin Transpl 1994:189-195. UI: 7547538.
10. Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Metter M, et al. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004; 18:62-69.
11. Bresson-Hadni S, Koch S, Miguet JP, Gillet M, Mantion GA, Heyd B, et al. Indications and results ofliver transplantation for Echinococcus alveolar infection: An overview. Langenbecks Arch Surg 2003;388:231-238.
12. Markus BH, Duquesnoy RJ, Blaheta RA, Scholz M, Encke A. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions. Langenbecks Arch Surg 1998;383:87-94.
13. Pappo O, Ramos H, Starz1 TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19: 192-206.
14. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
15. Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, et al. Long-term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation database. Liver Transpl 2004; 10:1120-1130.
16. Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, et al. Recurrent hepatitis C in liver allografts: Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004;28:658-669.
17. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. HEPATOLOGY 2000; 31:792-799.
18. Knechtle SJ, Kalayolu M, D'Alessandro AM, Mason B, Pirsch JD, Sollinger HW, et al. Histocompatibility and liver transplantation. Surgery 1993;114:667-671; discussion 671-672.
19. Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". HEPATOLOGY 1993;17:1008-1015.
20. Muro, M, Marin L, Torio A, Moya-Quiles MR, Ontation J, Minguela A, et al. Effect of HLA matching on liver graft survival. Transplant Proc 1999; 31:2477-2479.
21. Gordon RD, Fung JJ, Iwatsuki S, Duquesnoy RJ, Starzi TE. Immunological factors influencing liver graft survival. Gastroenterol Clin N Am 1988; 17:53-59.
22. Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993;55:1067-1071.
23. Campos J, Quijano Y, Franco A, Eiras P, Lopez-Sancamaria M, Gamez M, et al. Beneficial effects of HLA class II incompatibility in living donor liver transplantation. Transplant Proc 2003;35:1888-1891.
24. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988;46:372-377.
25. Doran TJ, Geczy AF, Painter D, McCaughan G, Sheil AG, Susal C, et al. A large, single center investigation of the immunogenetic factors affecting liver transplantation [see comment]. Transplantation 2000;69:1491-1498.
26. Opelz G. Preliminary analysis of HLA matching in pancreas and liver transplantation. Collaborative Transplant Study. Transplant Proc 1993; 25:2652-2653.
27. Gunson BK, Hathaway M, Buckels JA, Mayer AD, Elias E, McMaster P, et al. HLA matching in liver transplantation: A retrospective analysis. Transplant Proc 1992;24:2434-2435.
28. Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, et al. Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation 2002;74:1175-1180.
29. Sawyer RG, Pelletier SJ, Spencer CE, Pruett TL, Isaacs RB. Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches [see comment]. Liver Transpl 2000;6:229-236.
30. Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM, Krom RA. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988;45:376-379.
31. Chen M, Wade J, Levy GA, Greig PD. Effect of HLA matching and T-and B-cell crossmatch on acute rejection and graft survival following liver transplantation. Transplant Proc 1994;26:2695-2696.
32. Wong T, Donaldson P, Devlin J, Williams R, Repeat HLA-B and -DR loci mismatching at second liver transplantation improves patient survival. Transplantation 1996;61:440-444.
33. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994;58:786-792.
34. Adler M, Gavaler JS, Duquesnoy R, Fung JJ, Svanas G, Starzl TE, et al. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg 1988;208:196-202.
35. Hirata M, Harihara Y, Kita Y, Hisatomi S, Miura Y, Yoshino H, et al. Impact of HLA matching in living-related liver transplantation. Transplant Proc 2000;32:2108-2109.
36. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. HEPATOLOGY 1998;28:638-645.
37. Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 1999;5:475-479.
38. Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001;345:1794-1800.
39. Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006:CD005161.
40. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation [see comment]. N Engl J Med 1996;334:815-820.
41. Langrehr JM, Puhl G, Bahra. M, Schmeding M, Spinelli A, Berg T, et al. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl 2006; 12:644-651.
42. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000;6:553-561.